2030 年までの北米抗体発見市場予測 - 地域別分析 - 抗体タイプ別 (モノクローナル抗体、ポリクローナル抗体、その他)、性質別 (ヒトおよびヒト化、キメラ、マウス)、サービス別 (ファージディスプレイ、ハイブリドーマ、トランスジェニック動物、単細胞、酵母ディスプレイ)、エンドユーザー別 (製薬およびバイオテクノロジー企業、研究機関、その他)

BMIRE00030774 | Pages: 94 | Biotechnology | Sep 2024 | Type: Regional | Status: Published
北米の抗体発見市場は、2022年に12,98,237.57百万米ドルと評価され、2030年までに22,01,692.41百万米ドルに達すると予想されています。また、2022年から2030年にかけて6.8%のCAGRを記録すると推定されています。

研究開発への投資の増加が北米の抗体発見市場を活性化

モノクローナル抗体やポリクローナル抗体などの抗体は、学術機関、研究機関、製薬機関や組織で応用されており、薬物やバイオマーカーの開発、その他の治療および臨床診断製品の開発に関連するいくつかの研究開発活動で使用されています。中小企業は毎年、研究開発投資の増加に注力しています。 2020年4月、米国連邦政府はコロナウイルス救済・救援・経済安全保障法(CARES法)に基づき、バイオメディカル先端研究開発局(BARDA)に35億ドルを割り当て、ワクチン、診断薬、治療薬、小分子医薬品有効成分(API)などの製造、生産、調達に対する財政支援を提供しました。さらに、製薬会社のバイオ・ラッドは、体外診断テストの開発のために、抗原、試薬、緩衝液とともに1万種類の抗体を提供しています。したがって、さまざまな疾患に対するより良い治療オプションを開発するための抗体発見に関連する研究開発活動への製薬会社の投資の増加は、抗体発見市場の成長を促進します。

北米の抗体発見市場の概要

北米の抗体発見市場は、米国、カナダ、メキシコに分割されています。この地域の市場成長は、がんの有病率の増加、抗体研究業界の強力な存在、および研究開発部門における技術の進歩によって決まります。アメリカがん協会によると、2020年に米国で約180万件の新たながん症例が診断され、約606,520人のがん関連死が記録されました。これにより治療用抗体の必要性が高まり、抗体発見市場の成長が促進されます。資金の急増により、新しい技術の開発、国や組織をまたいだリソースと専門知識のプール、既存の抗体治療に関する研究作業の実施が可能になります。これにより、免疫システムの理解が深まり、効果的で標的を絞った抗体が開発されました。さらに、資金の増加により、科学者は特定の抗体の有効性を評価するために必須の大規模な臨床試験を実施できます。

北米の抗体発見市場の収益と2030年までの予測(10億米ドル)

北米の抗体発見市場のセグメンテーション

北米の抗体発見市場は、抗体の種類、性質、サービス、エンドユーザー、国に分類されています。

抗体の種類に基づいて、北米の抗体発見市場は、モノクローナル抗体、ポリクローナル抗体、その他に分類されます。モノクローナル抗体セグメントは、2022年に北米の抗体発見市場で最大のシェアを占めました。

性質の面では、北米の抗体発見市場は、ヒトおよびヒト化、キメラ、およびマウスに分類されます。ヒトおよびヒト化セグメントは、2022年に北米の抗体発見市場で最大のシェアを占めました。

サービス別に見ると、北米の抗体発見市場は、ファージディスプレイ、ハイブリドーマ、トランスジェニック動物、単一細胞、および酵母ディスプレイに分かれています。ファージディスプレイセグメントは、2022年に北米の抗体発見市場で最大のシェアを占めました。

エンドユーザーに基づいて、北米の抗体発見市場は、製薬およびバイオテクノロジー企業、研究室、その他に分類されます。製薬およびバイオテクノロジー企業セグメントは、2022年に北米の抗体発見市場で最大のシェアを占めました。

国別に見ると、北米の抗体発見市場は米国、カナダ、メキシコに分類されます。2022年には米国が北米の抗体発見市場シェアを独占しました。

Charles River Laboratories International Inc、Creative Biolabs Inc、Evotec SE、Bruker Cellular Analysis Inc、BioDuro LLC、Sartorius AG、Aragen Life Sciences Ltd、Twist Bioscience Corp、NanoCellect Biomedical Inc、Biocytogen Pharmaceuticals Beijing Co Ltd.は、北米の抗体発見市場で事業を展開している大手企業の一部です。

TABLE OF CONTENTS

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Antibody Discovery Market - Key Market Dynamics

4.1 Market Drivers

4.1.1 Increasing Investments in Research & Development

4.1.2 Rising Incidence of Cancer

4.2 Market Restraints

4.2.1 High Cost of Production

4.3 Market Opportunities

4.3.1 Proliferation of Biotechnology Industry in Developing Regions

4.4 Future Trends

4.4.1 Developments for Custom Antibodies

4.5 Impact of Drivers and Restraints:

5. Antibody Discovery Market - North America Market Analysis

5.1 North America Antibody Discovery Market Revenue (US$ Million), 2020-2030

6. North America Antibody Discovery Market Analysis - by Antibody Type

6.1 Overview

6.2 Monoclonal Antibodies

6.2.1 Overview

6.2.2 Monoclonal Antibodies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

6.3 Polyclonal Antibodies

6.3.1 Overview

6.3.2 Polyclonal Antibodies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Others

6.4.1 Overview

6.4.2 Others: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Antibody Discovery Market Analysis - by Nature

7.1 Overview

7.2 Human and Humanized

7.2.1 Overview

7.2.2 Human and Humanized: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

7.3 Chimeric

7.3.1 Overview

7.3.2 Chimeric: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Murine

7.4.1 Overview

7.4.2 Murine: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Antibody Discovery Market Analysis - by Services

8.1 Overview

8.2 Phage Display

8.2.1 Overview

8.2.2 Phage Display: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

8.3 Hybridoma

8.3.1 Overview

8.3.2 Hybridoma: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Transgenic Animal

8.4.1 Overview

8.4.2 Transgenic Animal: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Yeast Display

8.5.1 Overview

8.5.2 Yeast Display: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

8.6 Single Cell

8.6.1 Overview

8.6.2 Single Cell: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Antibody Discovery Market Analysis - by End User

9.1 Overview

9.2 Pharmaceutical and Biotechnology Companies

9.2.1 Overview

9.2.2 Pharmaceutical and Biotechnology Companies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

9.3 Research Laboratories

9.3.1 Overview

9.3.2 Research Laboratories: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

9.4 Others

9.4.1 Overview

9.4.2 Others: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Antibody Discovery Market - Country Analysis

10.1 North America Market Overview

10.1.1 North America: Antibody Discovery Market - Revenue and Forecast Analysis - by Country

10.1.1.1 US

10.1.1.1.1 Overview

10.1.1.1.2 US: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.3 United States: Antibody Discovery Market Breakdown, by Antibody Type

10.1.1.1.4 United States: Antibody Discovery Market Breakdown, by Nature

10.1.1.1.5 United States: Antibody Discovery Market Breakdown, by Services

10.1.1.1.6 United States: Antibody Discovery Market Breakdown, by End User

10.1.1.2 Canada

10.1.1.2.1 Overview

10.1.1.2.2 Canada: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.3 Canada: Antibody Discovery Market Breakdown, by Antibody Type

10.1.1.2.4 Canada: Antibody Discovery Market Breakdown, by Nature

10.1.1.2.5 Canada: Antibody Discovery Market Breakdown, by Services

10.1.1.2.6 Canada: Antibody Discovery Market Breakdown, by End User

10.1.1.3 Mexico

10.1.1.3.1 Overview

10.1.1.3.2 Mexico: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.3 Mexico: Antibody Discovery Market Breakdown, by Antibody Type

10.1.1.3.4 Mexico: Antibody Discovery Market Breakdown, by Nature

10.1.1.3.5 Mexico: Antibody Discovery Market Breakdown, by Services

10.1.1.3.6 Mexico: Antibody Discovery Market Breakdown, by End User

11. Antibody Discovery Market-Industry Landscape

11.1 Overview

11.2 Growth Strategies in the Antibody Discovery Market

11.3 Inorganic Growth Strategies

11.3.1 Overview

11.4 Organic Growth Strategies

11.4.1 Overview

12. Company Profiles

12.1 Charles River Laboratories International Inc

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Creative Biolabs Inc

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Evotec SE

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Bruker Cellular Analysis Inc

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 BioDuro LLC

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Sartorius AG

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Aragen Life Sciences Ltd

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Twist Bioscience Corp

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 NanoCellect Biomedical Inc

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Biocytogen Pharmaceuticals Beijing Co Ltd

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

 

 

List of Tables

Table 1. North America Antibody Discovery Market Segmentation

Table 2. New Cancer Cases Worldwide, in 2020

Table 3. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type

Table 4. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature

Table 5. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services

Table 6. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 7. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type

Table 8. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature

Table 9. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services

Table 10. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 11. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type

Table 12. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature

Table 13. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services

Table 14. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 15. Recent Inorganic Growth Strategies in the Antibody Discovery Market

Table 16. Recent Organic Growth Strategies in the Antibody Discovery Market

Table 17. Glossary of Terms, Antibody Discovery Market

 

List of Figures

Figure 1. North America Antibody Discovery Market Segmentation, by Country

Figure 2. North America Antibody Discovery Market - Key Market Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. North America Antibody Discovery Market Revenue (US$ Million), 2020 - 2030

Figure 5. North America Antibody Discovery Market Share (%) - by Antibody Type (2022 and 2030)

Figure 6. Monoclonal Antibodies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Polyclonal Antibodies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Others: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. North America Antibody Discovery Market Share (%) - by Nature (2022 and 2030)

Figure 10. Human and Humanized: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Chimeric: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Murine: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. North America Antibody Discovery Market Share (%) - by Services (2022 and 2030)

Figure 14. Phage Display: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Hybridoma: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Transgenic Animal: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Yeast Display: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Single Cell: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. North America Antibody Discovery Market Share (%) - by End User (2022 and 2030)

Figure 20. Pharmaceutical and Biotechnology Companies: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. Research Laboratories: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 22. Others: North America Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. North America: Antibody Discovery Market, by Key Country - Revenue (2022) (US$ Million)

Figure 24. North America: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 25. US: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)

Figure 26. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)

Figure 27. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)

Figure 28. Growth Strategies in the Antibody Discovery Market

  1. Charles River Laboratories International Inc
  2. Creative Biolabs Inc
  3. Evotec SE
  4. Bruker Cellular Analysis Inc
  5. BioDuro LLC
  6. Sartorius AG
  7. Aragen Life Sciences Ltd
  8. Twist Bioscience Corp
  9. NanoCellect Biomedical Inc
  10. Biocytogen Pharmaceuticals Beijing Co Ltd
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America antibody discovery market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the North America antibody discovery market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America antibody discovery market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440